Pfizer, Astellas Say Final PROSPER Results Show XTANDI Extends Overall Survival

Pfizer Inc. (PFE) and Japan-based Astellas Pharma Inc. (ALPMY) on Friday announced final results from the overall survival or OS analysis of the Phase 3 PROSPER trial.

from RTT - Biotech https://ift.tt/2yNMcnQ
via IFTTT